NDC codes

FDA NDC Directory
Product NDC (as listed)68040-714Labeler and product segments. Claims need a package NDC.
Product NDC at billing width68040-0714Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
68040-714-08680400714081 BOTTLE, SPRAY in 1 CARTON (68040-714-08) / 10 g in 1 BOTTLE, SPRAYMarketed from Jun 28, 2021
68040-714-28680400714281 BOTTLE, SPRAY in 1 CARTON (68040-714-28) / 120 g in 1 BOTTLE, SPRAYMarketed from Jun 28, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Sernivo
Generic name (nonproprietary)
betamethasone dipropionate
Active ingredients
Betamethasone dipropionate — .5 mg/g
Dosage form
Spray
Route
Topical
Labeler
Primus Pharmaceuticals, Inc.NDC labeler code 68040
Product type
Prescription drug
Marketing category
NDA — New Drug ApplicationApplication NDA 208079
Marketing start
Listing expires
Other FDA classes
Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers
Product ID 68040-714_8310ee9a-2de4-4246-a1ed-6fd23d041962SPL ID 8310ee9a-2de4-4246-a1ed-6fd23d041962SPL set ID b1b3d1b0-da9b-11eb-ad76-0800200c9a66RxCUI 1738536, 1738541UNII 826Y60901U
Pharmacologic class
Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468040071408 followed by a unit qualifier and the quantity

Package 68040-0714-08. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

SERNIVO Spray is indicated for the treatment of mild to moderate plaque psoriasis in patients 18 years of age or older. SERNIVO Spray is a corticosteroid indicated for the treatment of mild to moderate plaque psoriasis in patients 18 years of age or older. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 68040-714

What is NDC 68040-714?
68040-714 is the product NDC for Sernivo (betamethasone dipropionate), Betamethasone dipropionate .5 mg/g spray, listed with the FDA by Primus Pharmaceuticals, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Sernivo (Betamethasone dipropionate).
What is the active ingredient?
Betamethasone dipropionate.
Who is the labeler?
Primus Pharmaceuticals, Inc., NDC labeler code 68040. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Sernivo?
None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in